Research & Innovation - Impact into Cancer - 2014
11 Mar 2014 - 11 Mar 2014 - Telford, UK
Building on the successful launch of a new Research and Innovation conference format for ELRIG, we are proud to announce another first.
Invasive cancer is the leading cause of death in the developed world and the number of instances worldwide continues to grow annually. Because of this, and the heterogeneous nature of the disease, many academics and companies focus their activities to the study of the disease and the development of new and improved therapeutics. This in turn drives technological innovation, and it is this that will be the focus of this R&I conference.
The three tracks of this meeting; Cancer: New Approaches to Understanding the Disease, Technologies and Innovation in Phenotypic Screening, and Natural Product Screening and Development, and the Vendor Exhibition, will provide the delegates with an insight into some of the cutting edge science and the technologies being utilised in the study of cancer.
ELRIG are proud to be working in partnership with the Marine Fungi Consortium to provide the Natural Product Screening and Development track.